Eco AH sees stronger demand from Asia


UK-based Eco Animal Health said its revenue and pre-tax earnings would likely exceed market expectations this year after stronger-than-expected demand for its Aivlosin drug in Asia. “Our business has delivered good progress in key international markets, especially Asia,” CEO David Hallas said. Aivl...

Sign in  as a member, or Join our Community  for free to unlock the full article.

Managing Editor and Editor, Asian Poultry Magazine, Jakarta, Indonesia. Arief discovered interesting trends in the regional poultry industry during VIV Asia 2023 and shared them in ‘4 factors driving growth of poultry production in Asia’.